Cameron N Fick
Overview
Explore the profile of Cameron N Fick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunne E, Fick C, Mastrogiacomo B, Tan K, Toumbacaris N, Vanstraelen S, et al.
JTCVS Open
. 2025 Jan;
22():458-469.
PMID: 39780816
Objective: To identify clinicopathologic and genomic features associated with brain metastasis after resection of lung adenocarcinoma (LUAD) and to evaluate survival after brain metastasis. Methods: Patients who underwent complete resection...
2.
Fick C, Linhares S, Schultz K, Esposito A, Coppersmith N, Pantel H, et al.
Front Surg
. 2024 Dec;
11:1503410.
PMID: 39624463
No abstract available.
3.
Liu Y, Lankadasari M, Rosiene J, Johnson K, Zhou J, Bapat S, et al.
Cell Rep Med
. 2024 Oct;
5(10):101777.
PMID: 39413736
Approximately 50% of patients with surgically resected early-stage lung cancer develop distant metastasis. At present, there is no in vivo metastasis model to investigate the biology of human lung cancer...
4.
Fick C, Dunne E, Toumbacaris N, Tan K, Mastrogiacomo B, Park B, et al.
J Thorac Cardiovasc Surg
. 2024 Jul;
169(2):445-453.e3.
PMID: 38950771
Objective: Research into the risk factors associated with late recurrence (>2 years after surgery) of lung adenocarcinoma is limited. We investigated the incidence of and clinicopathologic and genomic features associated...
5.
Fick C, Dunne E, Vanstraelen S, Toumbacaris N, Tan K, Rocco G, et al.
J Thorac Cardiovasc Surg
. 2024 May;
169(2):436-444.e6.
PMID: 38788834
Objective: There is a lack of knowledge regarding the use of prognostic features in stage I lung adenocarcinoma (LUAD). Thus, we investigated clinicopathologic features associated with recurrence after complete resection...
6.
Fick C, Dunne E, Sihag S, Molena D, Cytryn S, Janjigian Y, et al.
Ann Thorac Surg
. 2024 Feb;
118(1):130-140.
PMID: 38408631
Background: The current standard of care for locally advanced esophageal and gastroesophageal junction (GEJ) cancers includes neoadjuvant chemoradiotherapy or perioperative chemotherapy with surgical resection; however, disease-free survival in these patients...
7.
Dunne E, Fick C, Isbell J, Chaft J, Altorki N, Park B, et al.
Ann Thorac Surg
. 2024 Feb;
118(1):119-129.
PMID: 38316378
Background: Despite surgical resection, long-term survival of patients with resectable non-small cell lung cancer (NSCLC) remains poor. Adjuvant chemotherapy, the standard of care for locally advanced NSCLC, provides a marginal...
8.
Fick C, Dunne E, Lankadasari M, Mastrogiacomo B, Asao T, Vanstraelen S, et al.
JTCVS Open
. 2024 Jan;
16:9-16.
PMID: 38204702
No abstract available.
9.
Dunne E, Fick C, Tan K, Toumbacaris N, Mastrogiacomo B, Adusumilli P, et al.
J Thorac Cardiovasc Surg
. 2023 Dec;
168(2):364-373.e10.
PMID: 38042400
Objectives: The study objectives were to assess the outcomes of lung resection in patients with non-small cell lung cancer previously treated with nonoperative treatment and to identify prognostic factors associated...
10.
Dunne E, Fick C, Jones D
J Clin Oncol
. 2023 Jun;
41(22):3785-3790.
PMID: 37267507
Journal of Clinical Oncology, Accurate staging of the mediastinal lymph nodes in resectable non-small-cell lung cancer (NSCLC) is critically important to determine the overall stage of the tumor and guide...